250mg Lapatinib Tablet

Name: 250mg Lapatinib Tablet
Brand: GLOBMED INDIA
Price: 7128 INR
Availability: InStock

Price 7128 INR/ Bottle

Get a Price/Quote

MOQ : 10 Strips

250mg Lapatinib Tablet Specification

Dosage Form
Tablet

Salt Composition
Lapatinib 250mg

Indication
Treatment of breast cancer

Feature
Oral use, film-coated tablet

Ingredients
Lapatinib

Application
Breast cancer therapy

Physical Color/Texture
Tablet, likely white/off-white

Storage Instructions
Store in a cool, dry place

Storage Temperature
Below 30C

Antineoplastic Agent
Yes

Patient Group
Adults

Brand Name
LANIB 250

Marketed By
BDR Pharmaceuticals

Packaging Size
30 tablets bottle

Generic Name
Lapatinib 250mg

Tablet Shape
Round

Prescription Required
Yes

Route of Administration
Oral

Strength
250 mg

Type
Prescription medicine

250mg Lapatinib Tablet Trade Information

Minimum Order Quantity
10 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Strips Per Month

Delivery Time
2-5 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

250mg Lapatinib Tablet About

LANIB 250 (Lapatinib 250mg tablet) by BDR Pharmaceuticals delivers a fresh, superb approach to breast cancer therapy. Each value-oriented bottle contains 30 round, film-coated tablets, exquisitely crafted for oral administration in adults. Top-tier in quality and customizable for varied treatment plans, LANIB 250 operates as a potent antineoplastic agent, ideal for prescription use. Its salt composition ensures consistent efficacy, while stringent storage requirements below 30C preserve performance. Choose LANIB 250 for a reliable, high-value treatment solution, expertly supplied by leading exporters in India.

LANIB 250 (Lapatinib 250mg): Standout Features & Specialized Use

LANIB 250 offers exemplary oral therapy for adult patients battling breast cancer. Each film-coated, round tablet is designed for easy administration and consistent therapeutic dosing. The product's exquisite composition and stability make it a top-tier prescription medicine in oncology. Suitable for use in hospital and clinical settings, its adaptable dosage forms empower oncologists to tailor treatment regimens for superb therapeutic impact. Its extra feature includes a secure bottle packaging that ensures safety and medication freshness throughout treatment.

Export Markets: FOB Port, Packaging & Sampling for LANIB 250 Tablets

LANIB 250 is primed for export, with bottles securely packaged to retain product integrity during transit. FOB port options are available according to buyer requirements, providing enhanced flexibility for international clients. Quotations are provided swiftly in response to export market inquiries, and product samples can be handed over upon request and subject to a mutually agreed sample policy. Every order is managed with diligence to ensure clients receive quality medicines promptly and reliably.

FAQ's of 250mg Lapatinib Tablet:

Q: How should LANIB 250 (Lapatinib 250mg) tablets be stored for maximum efficacy?

A: LANIB 250 tablets should be stored below 30C in a cool, dry place to maintain their stability and effectiveness.

Q: What is the primary use of LANIB 250 tablets?

A: LANIB 250 tablets are primarily indicated for the treatment of breast cancer in adult patients as part of a supervised therapy plan.

Q: When should LANIB 250 be administered?

A: LANIB 250 should be administered as prescribed by your healthcare provider, typically in accordance with a specific oncology treatment regimen.

Q: Where can LANIB 250 be sourced for export or supply purposes?

A: LANIB 250 is marketed and supplied by BDR Pharmaceuticals and is available through reputable exporters, suppliers, and traders, especially in India.

Q: What is the process for obtaining a sample or quotation for LANIB 250 tablets?

A: Interested buyers can request a quotation, and sample requests are considered based on the companys sample policy. Samples can be handed over after meeting requisite formalities.

Q: How does LANIB 250 benefit patients undergoing breast cancer therapy?

A: LANIB 250 provides a high-quality, custom-dose antineoplastic agent that offers consistent oral dosing and significant therapeutic value, helping improve outcomes for breast cancer patients.

Tell us about your requirement